What are the risks associated with autologous fat facial grafting?

Autologous fat grafting for facial rejuvenation—commonly referred to as fat transfer or fat injection—is a surgical procedure in which adipose tissue is harvested from one area of the body (typically the abdomen, thighs, or flanks), processed, and then reinjected into facial regions to restore volume, improve contour, and enhance youthful appearance. While generally considered safe when performed by an experienced, board-certified plastic surgeon or dermatologic surgeon, it carries several well-documented risks and potential complications.

Common short-term risks include bruising, swelling, temporary numbness, and mild asymmetry—most of which resolve spontaneously within days to weeks. More significant concerns involve fat necrosis, where portions of the transferred fat fail to establish adequate blood supply and undergo ischemic death; this may manifest as firm, palpable nodules or visible irregularities in the skin surface. Oil cysts and calcifications can also develop months to years later as sequelae of fat necrosis.

Infection, though rare with strict aseptic technique, remains a serious risk requiring prompt antibiotic therapy or, in severe cases, surgical drainage. Vascular complications—including inadvertent intravascular injection—pose the most critical danger: embolization of fat into the ophthalmic or central retinal artery may result in sudden, irreversible vision loss, while emboli in cerebral vessels could lead to stroke. These catastrophic events are exceedingly rare but underscore the importance of using blunt-tipped cannulas, low-pressure injection techniques, and meticulous anatomical knowledge.

Long-term considerations include variable graft survival (typically 40–70% retention at 6–12 months), leading to unpredictable or suboptimal aesthetic outcomes that may necessitate repeat procedures. Additionally, weight fluctuations can affect grafted fat volume, as surviving adipocytes retain metabolic responsiveness to systemic hormonal and nutritional changes. Patients with certain comorbidities—such as uncontrolled diabetes, active smoking, or significant peripheral vascular disease—face higher complication rates and should undergo thorough preoperative evaluation.

A comprehensive discussion of these risks, alongside realistic expectations and alternative treatment options (e.g., hyaluronic acid fillers, structural implants, or non-surgical modalities), is essential during informed consent. Careful patient selection, meticulous surgical technique, and adherence to evidence-based protocols significantly mitigate risk and optimize safety and satisfaction.